Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

MSLP

Muscle Pharm (CE) (MSLP)

Muscle Pharm Corporation (CE)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:MSLP
DatumZeitQuelleÜberschriftSymbolFirma
10/03/202322h17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
11/01/202312h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
21/12/202223h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:MSLPMuscle Pharm Corporation (CE)
19/09/202212h00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
23/08/202222h54Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
22/08/202223h09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
17/08/202212h01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
28/07/202222h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
28/07/202222h18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:MSLPMuscle Pharm Corporation (CE)
12/07/202223h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
22/06/202222h06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
17/06/202212h04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:MSLPMuscle Pharm Corporation (CE)
14/06/202222h11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
09/06/202222h27Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
17/05/202222h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
16/05/202223h08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
28/04/202214h16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
01/04/202201h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:MSLPMuscle Pharm Corporation (CE)
31/03/202222h01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:MSLPMuscle Pharm Corporation (CE)
11/03/202222h56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
22/02/202217h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:MSLPMuscle Pharm Corporation (CE)
29/12/202122h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
17/11/202112h05Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
16/11/202112h08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
02/11/202119h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
13/10/202122h53Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
01/10/202112h03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
16/08/202122h47Edgar (US Regulatory)Quarterly Report (10-q)USOTC:MSLPMuscle Pharm Corporation (CE)
16/08/202122h42Edgar (US Regulatory)Current Report Filing (8-k)USOTC:MSLPMuscle Pharm Corporation (CE)
27/07/202101h16GlobeNewswire Inc.MusclePharm Closes Potential $7.3 Million Liability with IRSUSOTC:MSLPMuscle Pharm Corporation (CE)
 Showing the most relevant articles for your search:USOTC:MSLP